Skip to content

Blood metabolome profiling for phenotyping severe asthma in Japan

Blood metabolome profiling for phenotyping severe asthma in Japan - NHOM-metabolomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042342
Enrollment
200
Registered
2020-11-05
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

None listed

Sponsors

National Hospital Organization Tokyo National Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Asthma (1) severe asthma (2) patient visiting participating hospitals (3) patient with informed consent (4) age above 16 Healthy Control (1) age above 16 (2) subject with informed consent (3) subject without any disease

Exclusion criteria

Exclusion criteria: subject whom the investigator thinks not appropriate for participation in this study

Design outcomes

Primary

MeasureTime frame
Metabolome profiling among severe asthma phenotypes

Countries

Japan

Contacts

Public ContactMaho Suzukawa

National Hospital Organization Tokyo National Hospital Clinical Research Center

fueta-tky@umin.ac.jp042-491-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026